CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors

RE Wilcox, WH Huang, MYK Brusniak… - Journal of medicinal …, 2000 - ACS Publications
Agonist affinity changes dramatically as a result of serine to alanine mutations (S193A,
S194A, and S197A) within the fifth transmembrane region of D2 dopamine receptors and …
被引用次数：69 相关文章

CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.

RE Wilcox, WH Huang, MY Brusniak… - Journal of Medicinal …, 2000 - europepmc.org
Agonist affinity changes dramatically as a result of serine to alanine mutations (S193A,
S194A, and S197A) within the fifth transmembrane region of D2 dopamine receptors and …
[PDF] academia.edu

[PDF][PDF] CoMFA-Based Prediction of Agonist Affinities at Recombinant Wild Type versus Serine to Alanine Point Mutated D2 Dopamine Receptors

RE Wilcox, WH Huang, MYK Brusniak, DM Wilcox… - J. Med. Chem, 2000 - academia.edu
Agonist affinity changes dramatically as a result of serine to alanine mutations (S193A,
S194A, and S197A) within the fifth transmembrane region of D2 dopamine receptors and …

CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors

RE Wilcox, WH Huang, MYK Brusniak… - Journal of Medicinal …, 2000 - ohsu.elsevierpure.com
Agonist affinity changes dramatically as a result of serine to alanine mutations (S193A,
S194A, and S197A) within the fifth transmembrane region of D2 dopamine receptors and …

[引用][C] CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors

RE WILCOX, WH HUANG… - Journal of medicinal …, 2000 - pascal-francis.inist.fr
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to
alanine point mutated D2 dopamine receptors CNRS Inist Pascal-Francis CNRS Pascal …
[PDF] psu.edu

[PDF][PDF] CoMFA-Based Prediction of Agonist Affinities at Recombinant Wild Type versus Serine to Alanine Point Mutated D2 Dopamine Receptors

RE Wilcox, WH Huang, MYK Brusniak, DM Wilcox… - J. Med. Chem, 2000 - Citeseer
Agonist affinity changes dramatically as a result of serine to alanine mutations (S193A,
S194A, and S197A) within the fifth transmembrane region of D2 dopamine receptors and …

CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors

RE Wilcox, WH Huang, MY Brusniak… - Journal of …, 2000 - pubmed.ncbi.nlm.nih.gov
Agonist affinity changes dramatically as a result of serine to alanine mutations (S193A,
S194A, and S197A) within the fifth transmembrane region of D2 dopamine receptors and …

[引用][C] CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors

RE WILCOX, WH HUANG… - Journal of …, 2000 - American Chemical Society